MediCA group has been acquired by Repharm
CGP Management has sold MediCA group, the largest private provider of healthcare services in Lithuania, to Repharm.
MediCA group is present in all levels of the healthcare system with primary, specialist and hospital care being the core business areas. Primary and selected specialist care services are provided in 30 clinics across Lithuania under the brand name MediCA. Kardiolitos Klinikos, which is the only private hospital in Lithuania, has three specialist centers, located in Vilnius, Kaunas, and Šiauliai, providing inpatient and outpatient healthcare services and is a nationally acknowledged center of excellence for cardiology services.
Repharm is a Latvian group of companies providing a wide range of healthcare services, from healthy lifestyle counseling to diagnosis and treatment. The group includes Sentor Farm Aptiekas (pharmacies operating under the Mēness Aptieka brand), Veselības Centru Apvienība (a chain of private clinics), Centrālā Laboratorija (a medical laboratory), Rīgas farmaceitiskā fabrika (a manufacturer of galenic preparations, soft pharmaceuticals and herbal drugs and teas) and Recipe Plus (wholesale trader of pharmaceutical and healthcare products).
Oaklins’ team in Lithuania advised CGP Management on the sale of MediCA group to Repharm.
Alvydas Barsteiga
Member of the Board, CGP Management
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more